Patents by Inventor Jonathan Michaud-Levesque

Jonathan Michaud-Levesque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide compounds derived from melanotransferrin and uses thereof
    Patent number: 9334314
    Abstract: Peptide compounds derived from human melanotransferrin, and compositions thereof, are described. Uses of these peptide compounds, for example to modulate angiogenesis and/or cell migration, and/or to treat angiogenesis-related disorders (e.g., cancer), are also described.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: May 10, 2016
    Assignee: THERATECHNOLOGIES INC.
    Inventors: Richard Béliveau, Jonathan Michaud-Levesque, Krishna G. Peri, Abdelkrim Habi, Nathalie Bousquet-Gagnon
  • PEPTIDE COMPOUNDS DERIVED FROM MELANOTRANSFERRIN AND USES THEREOF
    Publication number: 20150133385
    Abstract: Peptide compounds derived from human melanotransferrin, and compositions thereof, are described. Uses of these peptide compounds, for example to modulate angiogenesis and/or cell migration, and/or to treat angiogenesis-related disorders (e.g., cancer), are also described.
    Type: Application
    Filed: October 18, 2012
    Publication date: May 14, 2015
    Inventors: Richard Béliveau, Jonathan Michaud-Levesque, Krishna G. Peri, Abdelkrim Habi, Nathalie Bousquet-Gagnon
  • Compounds for stimulating P-glycoprotein function and uses thereof
    Patent number: 8487072
    Abstract: The present invention is directed to polypeptides (e.g., fragments) derived from P-glycoprotein and caveolin-1 which are capable of inhibiting the interaction between these two proteins. Inhibition of this interaction leads to increase of efflux of compounds that are transported by P-gp. The invention further includes methods of treating patients having diseases that benefit from increased P-gp-mediated efflux. Such diseases include neoplasms such as cancer and neurological diseases such as neurodegenerative diseases.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: July 16, 2013
    Assignee: Angiochem Inc.
    Inventors: Richard Beliveau, Michel Demeule, Stephane Barakat, Jonathan Michaud-Levesque
  • COMPOUND AND METHOD FOR REGULATING PLASMINOGEN ACTIVATION AND CELL MIGRATION
    Publication number: 20110243952
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Application
    Filed: March 28, 2011
    Publication date: October 6, 2011
    Applicant: TRANSFERT PLUS
    Inventors: Richard Béliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yannève Rolland, Julie Jodoin
  • COMPOUNDS FOR STIMULATING P-GLYCOPROTEIN FUNCTION AND USES THEREOF
    Publication number: 20110218152
    Abstract: The present invention is directed to polypeptides (e.g., fragments) derived from P-glycoprotein and caveolin-1 which are capable of inhibiting the interaction between these two proteins. Inhibition of this interaction leads to increase of efflux of compounds that are transported by P-gp. The invention further includes methods of treating patients having diseases that benefit from increased P-gp-mediated efflux. Such diseases include neoplasms such as cancer and neurological diseases such as neurodegenerative diseases.
    Type: Application
    Filed: October 19, 2007
    Publication date: September 8, 2011
    Inventors: Richard Beliveau, Michel Demeule, Stephane Barakat, Jonathan Michaud-Levesque
  • Compound and method for regulating plasminogen activation and cell migration
    Patent number: 7919103
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: April 5, 2011
    Assignee: Transfert Plus
    Inventors: Richard Béliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yannève Rolland, Julie Jodoin
  • Compound and method for regulating plasminogen activation and cell migration
    Publication number: 20070053894
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Application
    Filed: May 7, 2004
    Publication date: March 8, 2007
    Applicant: TRANSFERT PLUS
    Inventors: Richard Beliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yanneve Rolland, Julie Jodoin